PHARMA NEWS
45 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by srinath babu
Scoop.it!

Latest News on Cancer-Fueling RNAs a New Prostate Drug Target | PharmaExpress

Latest News on Cancer-Fueling RNAs a New Prostate Drug Target | PharmaExpress | PHARMA NEWS | Scoop.it
srinath babu's insight:

A team of potent researchers from UC Davis, UC San Diego and other institutions has identified a key mechanism behind aggressive prostate cancer. This abstract published in Nature, the study shows that two long non-coding RNAs (PRNCR1 and PCGEM1) activate androgen receptors, circumventing androgen-deprivation therapy.


In their active state, these receptors turn on genes that spur growth and metastasis, making these cancers highly treatment-resistant. The study explains how prostate cancer can thrive, even when deprived of hormones, and provides tempting targets for new therapies.


Read more @ http://pharmaexpress.net/articles/latest-news-on-cancer-fueling-rnas-a-new-prostate-drug-target



more...
No comment yet.
Scooped by srinath babu
Scoop.it!

Chinese Biotech Firm Joins Connecticut Network to Bridge East/West Drug Development Gap | PharmaExpress

Chinese Biotech Firm Joins Connecticut Network to Bridge East/West Drug Development Gap | PharmaExpress | PHARMA NEWS | Scoop.it
srinath babu's insight:

Connecticut United for Research Excellence, the state’s main bioscience industry group, has added a Chinese company founded by two people who received their graduate degrees in the U.S. and worked at a major pharmaceutical company in Ridgefield.

 

The company, HLK Biotechnology Co., is the first Chinese firm to join the network. HLK, based in a high-tech industrial zone of Shenzhen in the Guangdong province, says it hopes to act as a portal between Connecticut and Chinese bioscience companies.

 

Read more @ http://pharmaexpress.net/articles/chinese-biotech-firm-joins-connecticut-network-to-bridge-eastwest-drug-development-gap

more...
No comment yet.
Scooped by srinath babu
Scoop.it!

US to Hike fees for Generic Drug Makers – Indian Firms to be hit | PharmaExpress

US to Hike fees for Generic Drug Makers – Indian Firms to be hit | PharmaExpress | PHARMA NEWS | Scoop.it
srinath babu's insight:

The Global Pharma community regards Pharmaexpress to be transcendent growing online community which shares many quality based details across the globe.  The professional members of Pharmaexpress were quick to react about the news of the US health regulator FDA of hiking the fees for generic drugmakers by up to 48 per cent from October. This controversial suggestion was marveled by Pharma Community in United States of America.


Read more @ http://pharmaexpress.net/news/us-to-hike-fees-for-generic-drug-makers-indian-firms-to-be-hit

more...
No comment yet.
Scooped by srinath babu
Scoop.it!

Medical News Today – July 23 – Aug 8 | PharmaExpress

Medical News Today – July 23 – Aug 8 | PharmaExpress | PHARMA NEWS | Scoop.it
srinath babu's insight:
Intestinal cell findings may enable drug makers to increase absorption of medicines taken by mouth A new study reports that the small intestine uses more cells than scientists had realized to absorb microspheres large enough … Read more @ http://pharmaexpress.net/news/medical-news-today-july-23-aug-8
more...
No comment yet.
Scooped by srinath babu
Scoop.it!

Drug Safely Cuts Prostate Cancer Risk | PharmaExpress

Drug Safely Cuts Prostate Cancer Risk | PharmaExpress | PHARMA NEWS | Scoop.it
srinath babu's insight:

The long-term results from a major federal study ease worries about the safety of a hormone-blocking drug that can lower a man’s chances of developing prostate cancer. The drug cut prostate cancer risk by 30 percent without raising the risk of dying of an aggressive form of the disease as earlier results hinted it might.

 

Experts say it could prevent tens of thousands of cases each year, saving many men from treatments with seriously unpleasant side effects. The drug is sold as Proscar by Merck & Co. and in generic form as finasteride to treat urinary problems from enlarged prostates. It’s also sold in a lower dose as Propecia to treat hair loss.

 

Read more @ http://pharmaexpress.net/articles/drug-safely-cuts-prostate-cancer-risk

more...
No comment yet.
Scooped by srinath babu
Scoop.it!

How to Increase Pharma Sales Effectively? | PharmaExpress

How to Increase Pharma Sales Effectively? | PharmaExpress | PHARMA NEWS | Scoop.it
srinath babu's insight:
Pharmaceutical sales representative is fast becoming the best career to have because of the money that a person can make, and there is also a lot of opportunity to see different parts of the country. However, once someone gets into pharmaceutical sales, it is important that the sales numbers keep on growing, or a person may find themselves out of a job quickly. The world of pharma sales can be quite competitive, and there may be pressure to stay ahead. To help keep a pharma sales agent one step ahead of everyone else, here is more information on how to increase pharma sales effectively. Read more @ http://pharmaexpress.net/articles/how-to-increase-pharma-sales-effectively
more...
No comment yet.
Scooped by srinath babu
Scoop.it!

Sun Pharma to Pay Rs 2,517 cr to settle Patent Suit

srinath babu's insight:
The media core members of Pharmaexpress were haste to react about the news of the Sun Pharmaceutical Industries announcing to pay its dues of Rs 2,517.41 crore soon. The settlement agreement has reached successfully with Wyeth (now a division of Pfizer Inc.) and Altana Pharma AG (now known as Takeda GmbH). Read more @ http://pharmaexpress.net/news/sun-pharma-to-pay-rs-2517-cr-to-settle-patent-suit
more...
No comment yet.